Skip to main content
峆一药业 logo

峆一药业 — Investor Relations & Filings

Ticker · 920478 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2025-08-06 Investor Presentation
Country CN China
Listing Beijing Stock Exchange 920478

About 峆一药业

http://www.heryipharma.com/

Anhui Heyi Pharmaceutical Co., Ltd. specializes in the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company focuses on providing high-quality chemical products for various therapeutic areas, including cardiovascular, central nervous system, and anti-infective treatments. With a strong emphasis on technological innovation and quality control, it operates advanced manufacturing facilities that adhere to international standards. Its product portfolio includes key intermediates for widely used medications, supporting both domestic and global pharmaceutical supply chains. The company leverages its expertise in complex chemical synthesis to offer customized solutions and reliable supply to its partners in the life sciences sector.

Recent filings

Filing Released Lang Actions
投资者关系活动记录表
Investor Presentation Classification · 90% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details a specific investor relations event held online on August 5, 2025, including Q&A about company projects, product lines, and business updates. The content is a record of an investor relations meeting rather than a formal financial report or earnings release. It does not contain financial statements or regulatory filings, nor is it an announcement of voting results or management changes. It is not a transcript of a conference call but a summary of an investor relations activity. Therefore, the document best fits the category of Investor Presentation (IP), as it provides detailed information for investors about company strategy, projects, and market position in a presentation-like format.
2025-08-06 Chinese
关于取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Anhui 峆一药业股份有限公司 regarding the receipt of an invention patent certificate issued by the National Intellectual Property Office. It describes the patent details, its impact on the company, and references the patent certificate as a filed document. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, or voting results. The document is a regulatory announcement about intellectual property rights, which does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it is not about a report. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories. The document length is short and focused on a patent announcement, confirming RNS classification with high confidence.
2025-06-16 Chinese
关于取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Anhui Xuyi Pharmaceutical Co., Ltd. regarding the receipt of an invention patent certificate issued by the National Intellectual Property Office. It details the patent name, patent number, and the positive impact on the company. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no meeting materials, or voting results. The document is an announcement about intellectual property rights, which does not fit into financial report categories. It is a regulatory announcement about a patent certificate. Given the content and length (597 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other categories.
2025-06-03 Chinese
2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an "Annual Equity Distribution Implementation Announcement" for the year 2024 by Anhui Xuyi Pharmaceutical Co., Ltd. It details the equity distribution plan including stock dividends and cash dividends, the record date, ex-dividend date, dividend recipients, dividend method, share changes, and related parameters. The document is an announcement of the dividend amount and distribution details to shareholders, including tax implications and timing. It is not a full financial report or annual report but specifically focuses on dividend distribution information. Therefore, it fits the category of Notice of Dividend Amount (DIV). The document length is 1927 characters, which is consistent with an announcement rather than a full report.
2025-05-20 Chinese
关于第五届董事会专门委员会换届的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of members to four specialized committees of the company's board of directors. It references compliance with company law, company articles, and board meeting rules. The content focuses on board committee composition and governance matters, with no financial data or report attached. This fits the category of Board/Management Information (MANG), as it announces changes in the company's board committees and their members.
2025-05-20 Chinese
第五届监事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolution from the first meeting of the fifth supervisory board of Anhui 峆一药业股份有限公司. It details the meeting date, attendance, agenda, and voting results related to the election of the supervisory board chairman. It references compliance with company law and internal rules, and mentions a related announcement about board and senior management changes. The content is focused on board/management information, specifically about the supervisory board election and leadership appointment. The document length is short (979 characters) and it is not a report or financial statement but an official announcement of board/management changes. Therefore, the appropriate classification is Board/Management Information (MANG).
2025-05-20 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.